Patent details

LUC00096 Product Name: Inotersen and salts thereof

Basic Information

Publication number:
LUC00096
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP117780718
Legal Status:
Inactive
Application number:
LUC00096
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1296
Marketing Authorization Type:
Marketing Authorization Date:
10/07/2018
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
02/01/2019
First Marketing Authorization date:
10/07/2018
Grant date:
14/04/2021
Activation date:
Publication date:
07/01/2019
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
10/07/2033
SPC Extension Expiration:
10/07/2033
Rejection date:
Withdrawal date:

Owner

From:
02/01/2019
 
 

Name:
Ionis Pharmaceuticals, Inc.
Address:
2855 Gazelle Court, Carlsbad, CA 92010, United States (US)

Agent

Name:
Dennemeyer & Associates S.A.
From:
02/01/2019
Address:
PO Box 1502, L-1015, LUXEMBOURG, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2021/06
Publication date:
04/05/2021
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
30/04/2031
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
02/01/2019 Application Form 5
02/01/2019 General Document 3
02/01/2019 General Document 2
14/04/2021 Outgoing Correspondence 1
07/01/2019 Publication 1
02/01/2019 General Document 1
02/01/2019 General Document 3
14/04/2021 Certificate 1
07/01/2019 Outgoing Correspondence 2
31/03/2021 Outgoing Correspondence 2
13/04/2021 Incoming Correspondence (Post) 1
14/04/2021 Publication 1
02/01/2019 General Document 35